LENZ Therapeutics’ (LENZ) Buy Rating Reaffirmed at HC Wainwright
HC Wainwright reissued their buy rating on shares of LENZ Therapeutics (NASDAQ:LENZ – Free Report) in a research report sent to investors on Wednesday,Benzinga reports. They currently have a $38.00 target price on the stock. A number of other research firms also recently issued reports on LENZ. TD Cowen started coverage on shares of LENZ […]
HC Wainwright reissued their buy rating on shares of LENZ Therapeutics (NASDAQ:LENZ – Free Report) in a research report sent to investors on Wednesday,Benzinga reports. They currently have a $38.00 target price on the stock. A number of other research firms also recently issued reports on LENZ. TD Cowen started coverage on shares of LENZ […]